Robuta

https://stanfordhealthcare.org/publications/804/804543.html 804543 | Stanford Health Care Brief Report: Role of Consolidation Durvalumab in patients with EGFR and HER2 Mutant Unresectable Stage III NSCLC. stanfordhealthcare